Cyted Health

Cyted Health is a gastrointestinal molecular diagnostics company developing minimally invasive testing for early detection and monitoring of oesophageal pre-cancer and cancer.

Its platform combines a swallowable capsule sponge cell collection device with AI-driven biomarker molecular assays to detect Barrett's oesophagus, oesophageal adenocarcinoma, and inflammatory oesophageal conditions without endoscopy.

The platform has been deployed in over 35,000 tests across NHS hospitals and primary care settings in the UK and has received FDA 510(k) clearance.